The BACTOVAC platform can be applicable for a wide range of bacterial toxins to produce toxoid antigens fast and effectively.

So far, it has been validated on a range of different toxins

from the bacterial pathogens such as,

• Clostridium difficile 
• Bordetella pertussis
• Uropathogenic E. coli (UPEC)
  
• Corynebacterium diphtheriae
• Vibrio cholerae
• Clostridium sordellii
  

... and we are continously working on validating more toxins.